CRISPR

In the Lab By Elizabeth Cooney

‘A terrific choice’: George Church salutes fellow CRISPR pioneers’ historic Nobel win

Health By Matthew Herper

Jennifer Doudna, now a Nobel winner, on CRISPR and its role in medical research

In the Lab By Sharon Begley and Elizabeth Cooney

Two female CRISPR scientists make history, winning Nobel Prize in chemistry for genome-editing discovery

In the Lab By Sharon Begley

Dust off the crystal ball: It’s time for STAT’s 2020 Nobel Prize predictions

Biotech By Andrew Joseph

Patent board delivers blow to University of California over its CRISPR invention claims

First Opinion By Josephine Johnston

The U.S. must do some heavy lifting to prepare for heritable genome editing

In the Lab By Gideon Gil

Virtual Event: CRISPR’s forward march

In the Lab By Sharon Begley

Gene-editing discovery could point the way toward a ‘holy grail’: cures for mitochondrial diseases

In the Lab By Sharon Begley

In its first tough test, CRISPR base editing slashes cholesterol levels in monkeys

Biotech By Jonathan Saltzman — Boston Globe

Verve, raising another $63 million, seeks to advance gene-editing treatment for heart disease

First Opinion By Matthias Evers and Michael Chui

The Bio Revolution is changing business and society

Biotech By Sharon Begley

Deluge of genome editing therapies ends research drought for sickle cell disease

Health By Sharon Begley

New CRISPR-based test for Covid-19 could be a simple, cheap at-home diagnostic, scientists say

Health By Rebecca Robbins, Damian Garde, and Adam Feuerstein

‘Science is very much a part of culture’: Siddhartha Mukherjee dives into the history of genetics in a new Ken Burns film

First Opinion By Neal Baer

Covid-19 is scary. Could a rogue scientist use CRISPR to conjure another pandemic?

In the Lab By Associated Press

In its first use inside the human body, CRISPR genome editing tested as blindness therapy

Biotech By Jonathan Saltzman — Boston Globe

Beam Therapeutics raises $180 million in IPO

The Readout LOUD By Damian Garde, Rebecca Robbins, and Adam Feuerstein

Listen: Biohacker Josiah Zayner on getting canceled, good news in cancer, and a long road in Ebola

First Opinion By Josephine Johnston

He Jiankui is going to jail. Would the U.S. criminally prosecute a rogue gene-editing researcher?

Don't Miss By STAT staff

What will 2020 bring for medicine and science? We asked 16 leaders for predictions

In the Lab By Sharon Begley

Creating Pig3.0, the world’s most CRISPR’d animal, raises hopes of transplantable organs

Biotech By Sharon Begley and Adam Feuerstein

First CRISPR treatment for blood diseases shows early benefits in two patients

In the Lab By Sharon Begley

You had questions for David Liu about CRISPR, prime editing, and advice to young scientists. He has answers

Business By Adam Feuerstein and Damian Garde

This is awkward: Genome editing startup Beam has competition — from one of its own cofounders

Biotech By Damian Garde and Adam Feuerstein

The ‘unbelievable journey’ of CRISPR, now on Netflix